R. Onodera

发表

Intravenous infusion of auto serum-expanded autologous mesenchymal stem cells in spinal cord injury patients: 13 case series

Yoichi M Ito, S. Waxman, J. Kocsis, 2021, Clinical Neurology and Neurosurgery.

Pharmacological Difference Between Platelet Aggregations in Cardioembolic Stroke Patients with Direct Oral Anticoagulants: A Pilot Study.

O. Honmou, Masahito Nakazaki, Yuko Kataoka-Sasaki, 2022, Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association.

Intramuscular Transplantation of G‐CSF‐Mobilized CD34+ Cells in Patients With Critical Limb Ischemia: A Phase I/IIa, Multicenter, Single‐Blinded, Dose‐Escalation Clinical Trial

T. Yamanaka, Y. Kihara, Y. Kurimoto, 2009, Stem cells.

Intravenous infusion of mesenchymal stem cells for protection against brainstem infarction in a persistent basilar artery occlusion model in the adult rat.

J. Kocsis, M. Sasaki, O. Honmou, 2019, Journal of neurosurgery.

Long-term clinical outcome after intramuscular implantation of bone marrow mononuclear cells (Therapeutic Angiogenesis by Cell Transplantation [TACT] trial) in patients with chronic limb ischemia.

H. Matsubara, S. Fukumoto, T. Murohara, 2008, American heart journal.

Intravenous infusion of mesenchymal stem cells delays disease progression in the SOD1G93A transgenic amyotrophic lateral sclerosis rat model

J. Kocsis, M. Sasaki, O. Honmou, 2021, Brain Research.

Topical insulin-like growth factor 1 treatment using gelatin hydrogels for glucocorticoid-resistant sudden sensorineural hearing loss: a prospective clinical trial

Y. Tabata, J. Ito, Shiro Tanaka, 2010, BMC medicine.

Intravenous infusion of mesenchymal stem cells promotes functional recovery in a rat model of chronic cerebral infarction.

J. Kocsis, M. Sasaki, O. Honmou, 2019, Journal of neurosurgery.

Title Topical insulin-like growth factor 1 treatment using gelatin hydrogels for glucocorticoid-resistant sudden sensorineural hearing loss : a prospective clinical trial

Y. Tabata, J. Ito, Shiro Tanaka, 2017 .

Bone marrow mononuclear cells versus G-CSF-mobilized peripheral blood mononuclear cells for treatment of lower limb ASO: pooled analysis for long-term prognosis

H. Matsubara, T. Murohara, S. Matoba, 2011, Bone Marrow Transplantation.

Long-term clinical outcomes for patients with lower limb ischemia implanted with G-CSF-mobilized autologous peripheral blood mononuclear cells.

T. Tsukamoto, S. Teramukai, M. Fukushima, 2010, Atherosclerosis.

Intravenous Infusion of Autoserum-Expanded Autologous Mesenchymal Stem Cells in Patients With Chronic Brain Injury: Protocol for a Phase 2 Trial

J. Kocsis, Y. Iwadate, M. Sasaki, 2022, JMIR research protocols.

Prevention of neointimal hyperplasia induced by an endovascular stent via intravenous infusion of mesenchymal stem cells.

J. Kocsis, S. Iihoshi, M. Sasaki, 2020, Journal of neurosurgery.

Long-term clinical outcome after intramuscular implantation of bone marrow mononuclear cells (Therapeutic Angiogenesis by Cell Transplantation [TACT] trial) in patients with chronic limb ischemia.

H. Matsubara, S. Fukumoto, T. Murohara, 2008, American heart journal.

Spinal cord injury treatment with intrathecal autologous bone marrow stromal cell transplantation: the first clinical trial case report.

C. Ide, T. Nakatani, Yoshihisa Suzuki, 2008, The Journal of trauma.

Elevated brain derived neurotrophic factor levels in plasma reflect in vivo functional viability of infused mesenchymal stem cells for stroke in rats.

J. Kocsis, T. Mikami, M. Wanibuchi, 2017, Journal of neurosurgical sciences.

Repeated infusion of mesenchymal stem cells maintain the condition to inhibit deteriorated motor function, leading to an extended lifespan in the SOD1G93A rat model of amyotrophic lateral sclerosis

J. Kocsis, M. Sasaki, O. Honmou, 2021, Molecular brain.

Intravenous infusion of mesenchymal stem cells inhibits intracranial hemorrhage after recombinant tissue plasminogen activator therapy for transient middle cerebral artery occlusion in rats.

J. Kocsis, T. Mikami, M. Wanibuchi, 2017, Journal of neurosurgery.

Intravenous administration of auto serum-expanded autologous mesenchymal stem cells in stroke.

Takuya Matsunaga, Osamu Honmou, Kiyohiro Houkin, 2011, Brain : a journal of neurology.

Mesenchymal stem cells: therapeutic outlook for stroke.

Osamu Honmou, Stephen G Waxman, S. Waxman, 2012, Trends in molecular medicine.

A novel approach to therapeutic angiogenesis for patients with critical limb ischemia by sustained release of basic fibroblast growth factor using biodegradable gelatin hydrogel: an initial report of the phase I-IIa study.

Y. Tabata, M. Komeda, Sumiko Yokoyama, 2007, Circulation journal : official journal of the Japanese Circulation Society.

Preservation of interhemispheric cortical connections through corpus callosum following intravenous infusion of mesenchymal stem cells in a rat model of cerebral infarction

J. Kocsis, M. Sasaki, O. Honmou, 2018, Brain Research.

Synergic Effects of Rehabilitation and Intravenous Infusion of Mesenchymal Stem Cells After Stroke in Rats

J. Kocsis, S. Ishiai, Daiki Tateyama, 2016, Physical Therapy.

Bilateral cortical hyperactivity detected by fMRI associates with improved motor function following intravenous infusion of mesenchymal stem cells in a rat stroke model

J. Kocsis, N. Mikuni, Y. Kataoka, 2013, Brain Research.